Constructing, developing, or upgrading pharmaceutical and biotech manufacturing facilities, laboratories, and equipment
Included in ACT-ID SUM-OF-ALL
Previously: ACT-A-A1FK2M, ACT-A-T4RWAC (v0 legacy ID)
Use this ID
Constructing, developing, or upgrading pharmaceutical and biotech manufacturing facilities, laboratories, and equipment (ACT-U-A1FK2M, act-id.io/act/ACT-U-A1FK2M)Use-of-proceeds verified as ACT-U-A1FK2M — Constructing, developing, or upgrading pharmaceutical and biotech manufacturing facilities, laboratories, and equipment{
"act_id": "ACT-U-A1FK2M",
"name": "Constructing, developing, or upgrading pharmaceutical and biotech manufacturing facilities, laboratories, and equipment",
"url": "https://act-id.io/act/ACT-U-A1FK2M"
}ACT-ID.io. "Constructing, developing, or upgrading pharmaceutical and biotech manufacturing facilities, laboratories, and equipment" (ACT-U-A1FK2M). Accessed [access date]. https://act-id.io/act/ACT-U-A1FK2M
@misc{actid_ACT_U_A1FK2M,
title = {Constructing, developing, or upgrading pharmaceutical and biotech manufacturing facilities, laboratories, and equipment},
howpublished = {\url{https://act-id.io/act/ACT-U-A1FK2M}},
note = {ACT-ID.io registry entry ACT-U-A1FK2M},
year = {2026}
}This ACT-U is used in these taxonomies 2
Each row is a taxonomy that binds this use-of-proceeds to one or more objectives. The coloured tags show the value-chain role (direct / enabling / transitional), the contribution sign (positive / neutral / negative), and the taxonomy's traffic-light classification where applicable.
Climate Resilience - Resilient Industry & Commerce economic_development
direct positive
Climate Resilience - Resilient Industry & Commerce economic_development
direct positive
Criteria 0
No criteria records yet.
Related activities in other taxonomies 1
When two taxonomies describe closely-related activities that aren't identical, ACT-ID records the relationship here. Click any row to see the related activity.
Overlaps with this one is broader
Semantic mapping (confidence: 0.80): Constructing pharmaceutical & biotech facilities encompasses the manufacture of medicinal products but includes broader infrastructure development beyond just the manufacturing activity itself.